Physician profile
Michael Aiello
NPI 1710448659
$23,004.51
in general payments reported to CMS, 2019-2025
14 companies · $2,386 in 2025
The $2,386 reported for 2025 was more than what 81% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2023: $18K · 2024: $2,248 · 2025: $2,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $17K · Food and Beverage: $3,851 · Travel and Lodging: $2,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $16,780.33 |
| Food and Beverage | $3,850.84 |
| Travel and Lodging | $2,266.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,980.77 | 2023-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $7,299.49 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Abbott Laboratories | $3,584.56 | 2023-2025 | Eterna, Proclaim |
| Globus Medical, INC. | $352.29 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $218.14 | 2024-2025 | Xtampza |
| Biotronik Nro, INC. | $156.57 | 2025 | Prospera |
| Spinal Simplicity, LLC | $93.70 | 2025 | Ha Minuteman G3-R |
| Saluda Medical Americas, INC. | $92.85 | 2025 | Evoke |
| Baudax Bio INC. | $64.13 | 2021 | |
| Spr Therapeutics, INC | $48.93 | 2025 | Sprint Pns System |
| Acacia Pharma INC | $42.76 | 2021 | |
| Bioventus LLC | $25.37 | 2024 | Durolane |
| Curonix LLC | $23.98 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $20.97 | 2025 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Aiello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.